U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
MOSUNETUZUMAB
LDJ89SS0YG
US Approved Rx (2022)
First approved in 2022
General
Names
13
Classification
1
Identifiers
8
Subunits
4
Related Substances
1
MOSUNETUZUMAB
LDJ89SS0YG
US Approved Rx (2022)
First approved in 2022
General
Approval Year
2022
324
Names
13
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
BTCT-4465A
Preferred Name
English
MOSUNETUZUMAB
Official Name
English
RG-7828
Code
English
MOSUNETUZUMAB [USAN]
Common Name
English
Mosunetuzumab [WHO-DD]
Common Name
English
Showing 1 to 5 of 13 entries
Previous
1
2
3
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of follicular lymphoma
FDA ORPHAN DRUG
663418
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
LDJ89SS0YG
PRIMARY
INN
10621
PRIMARY
CAS
1905409-39-3
PRIMARY
USAN
FG-70
PRIMARY
DAILYMED
LDJ89SS0YG
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
LDJ89SS0YG
MOSUNETUZUMAB